Koelker-Wolfe, E.; Marcus, K.J.; DuBois, S.G.; Catalano, P.J.; Shusterman, S.; Ioakeim-Ioannidou, M.; Elhalawani, H.; Yock, T.I.; MacDonald, S.M.; Haas-Kogan, D.A.;
et al. Hypofractionated Palliative Radiotherapy for Relapsed and Refractory High-Risk Neuroblastoma. Curr. Oncol. 2025, 32, 124.
https://doi.org/10.3390/curroncol32030124
AMA Style
Koelker-Wolfe E, Marcus KJ, DuBois SG, Catalano PJ, Shusterman S, Ioakeim-Ioannidou M, Elhalawani H, Yock TI, MacDonald SM, Haas-Kogan DA,
et al. Hypofractionated Palliative Radiotherapy for Relapsed and Refractory High-Risk Neuroblastoma. Current Oncology. 2025; 32(3):124.
https://doi.org/10.3390/curroncol32030124
Chicago/Turabian Style
Koelker-Wolfe, Ellery, Karen J. Marcus, Steven G. DuBois, Paul J. Catalano, Suzanne Shusterman, Myrsini Ioakeim-Ioannidou, Hesham Elhalawani, Torunn I. Yock, Shannon M. MacDonald, Daphne A. Haas-Kogan,
and et al. 2025. "Hypofractionated Palliative Radiotherapy for Relapsed and Refractory High-Risk Neuroblastoma" Current Oncology 32, no. 3: 124.
https://doi.org/10.3390/curroncol32030124
APA Style
Koelker-Wolfe, E., Marcus, K. J., DuBois, S. G., Catalano, P. J., Shusterman, S., Ioakeim-Ioannidou, M., Elhalawani, H., Yock, T. I., MacDonald, S. M., Haas-Kogan, D. A., & Liu, K. X.
(2025). Hypofractionated Palliative Radiotherapy for Relapsed and Refractory High-Risk Neuroblastoma. Current Oncology, 32(3), 124.
https://doi.org/10.3390/curroncol32030124
